Loss of Fgfr2 leads to partial XY sex reversal  by Bagheri-Fam, Stefan et al.
Available online at www.sciencedirect.com
314 (2008) 71–83
www.elsevier.com/developmentalbiologyDevelopmental BiologyLoss of Fgfr2 leads to partial XY sex reversal
Stefan Bagheri-Fam a, Helena Sim a, Pascal Bernard a, Irumini Jayakody b, Makoto M. Taketo c,
Gerd Scherer d, Vincent R. Harley a,⁎
a Human Molecular Genetics laboratory, Prince Henry's Institute of Medical Research, Monash Medical Centre, Melbourne 3168, Australia
b Department of Anatomy and Developmental Biology, Monash University, Melbourne 3800, Australia
c Department of Pharmacology, Graduate School of Medicine, Kyoto University, Yoshida-Konoé-cho, Kyoto 606-8501, Japan
d Institute of Human Genetics and Anthropology, University of Freiburg, D-79106 Freiburg, Germany
Received for publication 5 October 2007; revised 5 November 2007; accepted 8 November 2007
Available online 19 November 2007Abstract
In mammals, sex is determined in the bipotential embryonic gonad by a balanced network of gene actions which when altered causes disorders
of sexual development (DSD, formerly known as intersex). In the XY gonad, presumptive Sertoli cells begin to differentiate when SRY up-
regulates SOX9, which in turn activates FGF9 and PGDS to maintain its own expression. This study identifies a new and essential component of
FGF signaling in sex determination. Fgfr2 mutant XY mice on a mixed 129/C57BL6 genetic background had either normal testes, or developed
ovotestes, with predominantly testicular tissue. However, backcrossing to C57BL6 mice resulted in a wide range of gonadal phenotypes, from
hypoplastic testes to ovotestes with predominantly ovarian tissue, similar to Fgf9 knockout mice. Since typical male-specific FGF9-binding to the
coelomic epithelium was abolished in Fgfr2 mutant XY gonads, these results suggest that FGFR2 acts as the receptor for FGF9. Pgds and SOX9
remained expressed within the testicular portions of Fgfr2 mutant ovotestes, suggesting that the Prostaglandin pathway acts independently of
FGFR2 to maintain SOX9 expression. We could further demonstrate that double-heterozygous Fgfr2/Sox9 knockout mice developed ovotestes,
demonstrating that both Fgfr2 and Sox9 can act as modifier intersex genes in the heterozygous state. In summary, we provide evidence that
FGFR2 is important for male sex determination in mice, thereby rendering human FGFR2 a candidate gene for unsolved DSD cases such as
10q26 deletions.
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In mammals, sex determination is chromosomally con-
trolled, under the regulation of the sex-determining region of the
Y chromosome gene (SRY), which encodes a sequence-specific
DNA binding protein (Harley et al., 1992; Sinclair et al., 1990).Abbreviations: AMH, anti-Müllerian hormone; B6, C57BL6; Bmp2, bone
morphogenetic protein 2; Ck19, cytokeratin 19; Cyp26b1, cytochrome P450
26b1;Dmc1, disrupted meiotic cDNA 1; DSD, disorders of sexual development;
En, embryonic day n; FGF, fibroblast growth factor; FGFR, fibroblast growth
factor receptor; Fst, follistatin; PGD2, prostaglandin D2; Pgds, prostaglandin D
synthase; SCP3, synaptonemal complex protein 3; SOX9, SRY type high
mobility group box 9; SRY, sex-determining region of the Y chromosome;
Stra8, stimulated by retinoic acid gene 8; Wnt4, wingless-related MMTV
integration site 4.
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doi:10.1016/j.ydbio.2007.11.010The embryonic gonad normally develops into either a testis or
an ovary, but in DSD cases (disorders of sexual development,
formerly known as intersex; Hughes et al., 2006), an ovotestis
can occur that contains both testicular and ovarian tissue
(Brennan and Capel, 2004; Swain and Lovell-Badge, 1999). In
humans, mutations in SRY, SOX9, SF1, WT1 or DHH as well as
duplications of DAX1 or of WNT4 can upset the balanced
network of gene expression, causing XY gonadal dysgenesis or
XY sex reversal (Fleming and Vilain, 2005). The majority of
such DSD conditions, however, remain unexplained genetically.
Testis determination is best understood in the mouse. In the
XY gonad, Sry is expressed in bipotential supporting cells
(primordial Sertoli/follicle cells) at embryonic day 10.5 (E10.5)
and by E11.5 SRY triggers Sertoli cell fate by activating the
transcription of Sox9 (Brennan and Capel, 2004; Swain and
Lovell-Badge, 1999), an Sry-related, autosomal transcription
factor gene. Once Sertoli cells have differentiated, other
72 S. Bagheri-Fam et al. / Developmental Biology 314 (2008) 71–83bipotential cell types of the gonad (Leydig/theca, male/female
germ cells) become committed to the male pathway (McLaren
and Southee, 1997).
Mutations in human SOX9 lead to campomelic dysplasia, a
skeletal malformation syndrome with associated XY sex
reversal in two thirds of all XY cases (Foster et al., 1994;
Wagner et al., 1994). Mice lacking Sox9, like those lacking
Fibroblast growth factor 9 (Fgf9), undergo XY male-to-female
sex reversal as a consequence of the perturbations to early male-
specific events of gonad development (Barrionuevo et al., 2006;
Chaboissier et al., 2004; Colvin et al., 2001; Kim et al., 2006;
Schmahl et al., 2004). Sox9 is essential for expression of FGF9
which acts to maintain Sox9 expression by an unknown
mechanism (Kim et al., 2006). FGF9 in turn inhibits the female
pathway by down-regulating the expression of Wnt4.
The receptor that mediates FGF9 signals in sex determina-
tion is not known. FGF9 can bind to and activate all four FGF
receptors (FGFR1–4) in vitro (Ornitz et al., 1996) and all four
receptors are expressed in the somatic cells of XY and XX
gonads at E11.5 (Schmahl et al., 2004). Chimeric Fgfr1
knockout mice with 90% inactivation show normal testis
development, and Fgfr3 and Fgfr4 knockout mice are fertile
(Colvin et al., 1996; Deng et al., 1996, 1997; Weinstein et al.,
1998), indicating that these receptors are either not required for
sex determination, or they act redundantly. Rather unusually,
FGFR2 protein is localized male-specifically in the nucleus of
differentiating E11.5 Sertoli cells, co-incident with elevated
SOX9 protein expression (Schmahl et al., 2004). Therefore,
Fgfr2 is a good candidate sex determining gene.
Hitherto the obstacle to studying FGFR2 sex-determining
function has been that homozygous Fgfr2 knockout mice die
before sex determination occurs due to extraembryonic defects
(Xu et al., 1998). We circumvented this by conditionally
inactivating Fgfr2 only in the embryo proper. We show that
FGFR2 is important for male sex determination since Fgfr2
mutant XY mice, with gonadal phenotypes similar to Fgf9
knockout mice, and Fgfr2/Sox9 double heterozygous XY
knockout mice show gonadal male-to-female sex reversal.
Since we show that FGF9 does not bind to the coelomic
epithelium of Fgfr2 mutant XY gonads, our data support
FGFR2 being the receptor for FGF9.
Results
Conditional homozygous inactivation of Fgfr2 in the gonad
Complete Fgfr2 knockout mice die at around E10.5 prior to
sex determination, due to a malfunction in chorioallantoic
fusion or placental development (Xu et al., 1998). To
circumvent early embryonic lethality of complete Fgfr2
knockout mice, we used a conditional gene knockout approach
using the Ck19:Cre mouse line, which expresses Cre-recombi-
nase between E4.5 and E5.5 only in the embryo proper
(epiblast) (Means et al., 2005). We have shown previously by
using the Ck19:Cre line to inactivate Sox9, that gene
inactivation was highly efficient within the E11.5 XY male
genital ridge and that most Sox9 mutant XY embryos displayedcomplete male-to-female sex reversal (Barrionuevo et al., 2006).
Fgfr2flox/flox mice bred on a mixed 129/C57BL6 genetic back-
ground (Yu et al., 2003) were crossed with the Ck19:Cre/+
(C57BL6) transgenic mouse line (Means et al., 2005) to generate
Ck19:Cre/+;Fgfr2flox/+ offspring. These mice did not show an
obvious phenotype and were backcrossed to Fgfr2flox/flox mice
to obtain Ck19:Cre/+;Fgfr2flox/flox (‘Fgfr2 mutant’) embryos.
Fgfr2 mutant embryos were recovered at the expected
Mendelian ratio, but died immediately after birth. Fgfr2mutants
showed variable limb defects ranging from malformed and
shortened limbs to absence of limbs (Fig. 1A), reflecting
moderate to complete inactivation of the Fgfr2 gene. The latter
phenotype resembles that of complete Fgfr2 knockout embryos,
which also lack limbs (Xu et al., 1998). Immunohistochemistry
for FGFR2 at E12.5 revealed a drastic reduction of FGFR2-
positive Sertoli cells in Fgfr2 mutant XY gonads (70–100%
inactivation; see Fig. 1B for details), indicating that Fgfr2
inactivation was efficient (Fig. 1B).
Fgfr2 mutant XY gonads on a mixed 129/B6 background show
defects in testis cord formation
At E13.5, the XY male gonad is characterized by the
formation of the presumptive seminiferous tubules, known as
testis cords (Figs. 2A and B). To analyze if Fgfr2 mutant XY
mice show defects in testis cord formation, we performed gross
morphological and histological analyses of XY Fgfr2 mutant,
and XY and XX wild type gonads between E13.5 and E15.5.
25% of Fgfr2 mutant XY mice (10 gonads; 4 at E13.5, 4 at
E14.5 and 2 at E15.5) had normal testes (data not shown), while
75% (28 gonads; 14 at E13.5, 10 at E14.5 and 4 at E15.5)
showed defects in testis cord formation of varying severity
(Figs. 2A and B and data not shown). At E13.5 and E14.5, in
Fgfr2 XY mutants, testis cords were formed properly at the
center of the gonad (Fig. 2A and data not shown), whereas the
anterior pole (arrow in Fig. 2A), and less frequently the
posterior pole, contained either highly disorganized cords or
had an unstructured appearance similar to a female gonad (Figs.
2A and B, and Fig. 4B(i)) (see Fig. 2 for details). By E15.5, the
gonads appeared as ovotestes with the ovarian portion
predominantly located at the anterior pole of the gonad (arrow
in Fig. 2A). The postnatal development of Fgfr2 mutant gonads
could not be studied, since the Fgfr2 mutant mice die at birth. It
should be noted that of six embryos analyzed we did not observe
a significant correlation between the efficiency of FGFR2
inactivation (number of remaining FGFR2-positive cells) and
the severity of the phenotype (normal testis or ovotestis) (see
Fig. 1B for details), suggesting that the gonadal phenotype
might vary more strongly with other factors, such as the genetic
background of this mixed 129/C57BL6 mouse strain. In
summary, XY Fgfr2 mutant male gonads failed to form testis
cords at the gonad poles, leading to ovotestis formation.
Fgfr2 mutants show partial XY sex reversal
To investigate the course of gonadal sex reversal induced by
FGFR2 loss, we undertook a molecular analysis of Fgfr2 XY
Fig. 1. Conditional inactivation of Fgfr2 using Ck19:Cre. (A) Limb bud defects in Fgfr2 mutant embryos at E13.5. Arrowheads point to the hindlimbs, which are
absent in severely affected Fgfr2 mutant embryos. (B) Immunohistochemistry of frozen sections of Fgfr2 mutant XY and control gonads at E12.5 with an antibody
against FGFR2. The inserts in the top and bottom panels show magnifications of cells stained for DAPI (blue, nuclear) and FGFR2 (green, nuclear in the wild type XY
gonad and at the membrane in the wild type XX gonad). Efficiency of Fgfr2 inactivation was determined by counting the number of FGFR2-positive Sertoli cells per
section over four sections (more than 100 cells) in XY wild type and Fgfr2 mutant XY gonads. A total of six gonads from six different embryos have been analyzed,
revealing a drastic reduction of FGFR2-positive Sertoli cells (between 70% and 100% per gonad) in Fgfr2 mutant XY embryos. It should be noted that we did not
observe a significant correlation between the efficiency of FGFR2 inactivation (number of remaining FGFR2-positive Sertoli cells) and the severity of the phenotype
(normal testis or ovotestis). Of the six E12.5 Fgfr2mutant XY gonads analyzed, two were normal testes (approximately 70% and 100% inactivation), while four were
ovotestes (approximately 70% (2 gonads), 80% and 100% inactivation). Scale bars are 50 μm.
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embryos showed strong SRY and SOX9 protein expression,
indicating proper initiation of male sex determination (Fig. 3A).
However, by E12.5, while in wild type XYembryos, SOX9 and
AMH, a direct SOX9 target and specific marker of Sertoli cells,
were strongly co-expressed throughout the gonad; in Fgfr2
mutant XY gonads, the number of SOX9- and AMH-positive
cells was reduced near the poles of the gonad, particularly near
the anterior pole (Fig. 3B). Moreover, in contrast to SOX9-
expression levels (Fig. 3B, middle panel), AMH-expression
levels were drastically reduced at the poles (Fig. 3B, bottom
panel). By E14.5, SOX9 (Fig. 3C, upper panel) and AMH (Fig.
3C, lower panel) were absent at the poles, indicating a failure of
Sertoli cell differentiation at this location.
To investigate whether the poles of the Fgfr2 mutant male
gonads underwent a fate change and developed along the female
pathway, we analyzed the expression of the ovarian somatic cell
markers Wnt4 and Fst (Follistatin), by whole mount in situ
hybridization. Wnt4 is down-regulated by FGF9 during male
gonadal development (Kim and Capel, 2006; Kim et al., 2006)
and is one of the earliest known female markers (Vainio et al.,
1999), while Fst is a downstream component of Wnt4 signaling
(Yao et al., 2004). Wild type XY male gonads showed no Wnt4
and Fst expression, whereas XX female gonads displayed
strong Wnt4 and Fst expression throughout the entire gonad at
E12.5 and E14.5, respectively (Fig. 4A). Fgfr2 mutant XY
gonads showed Wnt4 and Fst expression specifically at their
poles, indicating that the somatic cells at the poles develop
along the female pathway (arrow in Fig. 4A).Mouse primordial germ cells proliferate until E13.5, then
enter into meiotic prophase in the female gonad or become
mitotically arrested in the male gonad (Hilscher et al., 1974). To
study the fate of germ cells in the Fgfr2 mutant ovotestis, we
first performed histological analyses of Fgfr2 mutant XY
gonads at E14.5 (Fig. 4B(i)). During meiotic prophase, the
chromosomes coil and become shorter and thicker and visible
under the light microscope. We found that, in Fgfr2 mutant XY
gonads, germ cells at the anterior pole, and less frequently at the
posterior pole, appeared to have entered meiotic prophase
(arrow in Fig. 4B(i)). This was confirmed by the expression
specifically at the gonads poles of Stra8 (encodes a pre-meiotic
marker) (Menke et al., 2003), and of the meiotic prophase
markers SCP3 (a component of the synaptonemal complex) and
Dmc1 (encodes a meiosis-specific recombinase) (Bullejos and
Koopman, 2004; Chuma and Nakatsuji, 2001; Di Carlo et al.,
2000; Menke et al., 2003) at the gonad poles (Fig. 4B(ii)).
Retinoic acid, produced by mesonephroi of both sexes, causes
germ cells in the ovary to enter meiosis and initiate oogenesis.
In the fetal testis, Sertoli cells secrete the retinoid-degrading
enzyme CYP26B1 thereby preventing meiosis, ultimately
leading to spermatogenesis (Bowles et al., 2006; Koubova et
al., 2006). In Fgfr2 mutant XY gonads Cyp26b1 expression
was absent from the gonad poles (Fig. 4B(ii), bottom panel),
which might explain why meiosis is restricted to the polar
regions. Taken together, the presence of the somatic female
markers Wnt4 and Fst, and of the pre-meiotic/meiotic markers
Stra8, Dmc1 and SCP3, strongly suggests that the poles of the
Fgfr2 mutant XY gonads are sex-reversed.
Fig. 2. Fgfr2 mutant XY gonads show defects in testis cord formation. (A) Light microscopy images of Fgfr2 mutant XY and control gonads at E13.5 and E15.5. In
wild type XY gonads, testis cords (bright regions) are visible through a light microscope, which are separated by peritubular tissue (dark regions). At the anterior pole
of Fgfr2 mutant XY gonads (arrows), testis cords were poorly distinguished from the peritubular tissue or appeared to be absent. (B) Hematoxylin and eosin (HE)
staining of sections of paraffin-embedded mutant and control embryos at E13.5 (Enlargements of the anterior regions of the gonads are shown). In wild type XY
gonads, testis cords (arrows point to examples of well formed testis cords) are separated by interstitial cells that define the peritubular space. Sertoli cells are present at
the periphery of the tubule and peritubular myoid (PTM) cells form a concentric layer of cells that surrounds the testis cord. Between PTM and Sertoli cells, a basal
lamina is formed which is visible as a thin line. The anterior pole of Fgfr2 mutant XY gonads contained either highly disorganized cords (as judged by the reduced
number of PTM cells and the lack of the basal lamina separating cords from the peritubular space), or had an unstructured appearance similar to a female gonad.
a, anterior; p, posterior. Scale bars are 50 μm.
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mutant XY gonads
The sex-reversal phenotype of Fgfr2 mutant XY gonads was
milder than that of Fgf9 knockout XY mice which were also
bred on a mixed 129/C57BL6 background (Colvin et al., 2001).
This may be attributable to differing genetic contribution of the
C57BL6 (B6) mouse strain, which is exquisitely sensitive to XY
sex reversal, as shown in Fgf9 andDax1 knockout mice (Bouma
et al., 2005; Colvin et al., 2001; Meeks et al., 2003; Schmahl et
al., 2004). To test whether the B6 mouse strain can exacerbate
the XY sex-reversal phenotype of Fgfr2 mutant gonads, we
backcrossed Ck19:Cre/+;Fgfr2flox/+ and Fgfr2flox/flox mice to
B6. Resultant Ck19:Cre/+;Fgfr2flox/+ (129/B6*) and Fgfr2flox/+
(129/B6*) mice were crossed with each other to generate Fgfr2
mutant (129/B6*) XY embryos. Gross morphological analyses
at E14.5 revealed a range of gonadal phenotypes, from ovotestes
with predominantly testicular tissue (8 gonads, data not shown),
to ovotestes with predominantly ovarian tissue (5 gonads) (Fig.
5A), to gonads the size and shape of ovaries (3 gonads) (Fig.
5A). Gonads of the latter phenotype lacked the male-specific
blood vessel altogether, while in ovotesticular gonads the blood
vessel was restricted to a region above the testis cords (Fig. 5A).The anterior region of the gonads was always more severely
affected than the posterior region. With increasing expressivity
of the ovarian phenotype among Fgfr2 mutant XY gonads, the
male markers SOX9 and AMH were gradually lost from pole to
center, particularly from the anterior pole (Figs. 5B and C, upper
panel). In more dramatic phenotypes, only few testis cords
remained (as evidenced by AMH-expression), restricted to a
small region just posterior to the center of the gonad (Fig. 5B(ii),
middle panel, and C, upper panel). Conversely, the female
somatic cell marker Bmp2was specifically absent only from this
restricted region (Fig. 5C, lower panel), confirming that these
gonads were predominantly ovaries. In one gonad examined, we
observed almost complete loss of SOX9 and AMH expressing
cells (Fig. 5B(ii), bottom panel). These data demonstrate that the
mouse strain C57BL6 exacerbates the phenotype of Fgfr2
mutant XY gonads, leading to almost complete sex reversal in
some cases.
Pgds expression persists in testis cords of Fgfr2 mutant and
Fgfr2 mutant (129/B6*) XY gonads
Our data show that SOX9 can still be widely expressed in
gonads lacking FGFR2 (Fig. 3C, upper panel and Fig. 5B(ii),
Fig. 3. The Sertoli cell markers SOX9 and AMH are reduced or absent from the poles of Fgfr2mutant XY gonads. (A) Fluorescence microscopy of frozen sections of
Fgfr2XYmutant and control gonads at E11.5 immunostained for Sertoli cell markers, SRY (red, nuclear) (upper panel) and SOX9 (green, nuclear) (lower panel). SRY
and SOX9 appear to be expressed normally in E11.5 Fgfr2 XY mutants. (B) Top panel: Fluorescence microscopy of frozen sections of E12.5 Fgfr2 mutant XY and
control gonads double immunostained for SOX9 (green, nuclear) and AMH (red, cytoplasmic). The middle and bottom panels represent magnifications of the same
gonad sections shown in the top panel in which the signals for SOX9 (middle panel) and AMH (bottom panel) have been separated. Fgfr2 mutant XY gonads show a
reduction of SOX9- and AMH-expressing cells near the poles of the gonad, particularly near the anterior pole. Over 100 SOX9-postive cells were counted in a defined
field in the anterior region (framed in middle and bottom panels). There were approximately 50% fewer SOX9-positive cells in Fgfr2mutant XY gonads compared to
XY control gonads (n=5). (C) Upper panel: Fluorescence microscopy of frozen sections of Fgfr2 mutant XY and control gonads at E14.5 immunostained for SOX9
(green, nuclear). Lower panel: Fluorescence microscopy of frozen sections of Fgfr2 mutant XY and control gonads at E14.5 immunostained for AMH (red,
cytoplasmic). At E14.5, SOX9 and AMH are absent at the poles (arrow) of Fgfr2 mutant XY gonads. a, anterior; c, center; p, posterior. All scale bars are 50 μm.
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maintain SOX9 expression. Evidence is emerging that SOX9
also participates in a SOX9–PGDS (Prostaglandin D
Synthase)–PGD2 (Prostaglandin D2) positive loop. SOX9
directly regulates Pgds transcription in vivo (Wilhelm et al.,
2007). Conversely, PGD2 promotes accumulation of SOX9 in
the nucleus via an importin beta pathway as demonstrated by
Malki et al. (2005); in cultured XX gonads, PGD2 can induceSox9 transcription (Wilhelm et al., 2005). Together, these data
support a positive feedback loop between SOX9 and PGD2.
To investigate whether the PGDS/PGD2-pathway might still
be active within the testicular regions of Fgfr2 mutant and
Fgfr2 mutant (129/B6*) XY gonads, we analyzed the
expression of Pgds by whole mount in situ hybridization. At
E13.5/E14.5, the XY gonad expresses Pgds in Sertoli cells of
the testis cords, while the XX gonad does not express Pgds
Fig. 4. The poles of Fgfr2mutant XY gonads develop along the female pathway. (A) Upper panel: Whole mount in situ hybridization forWnt4 of E12.5 Fgfr2mutant
XYand control gonads. Lower panel: Whole mount in situ hybridization for the female somatic cell marker Fst of E14.5 Fgfr2mutant XYand control gonads. Arrows
point to theWnt4- and Fst-positive poles of the Fgfr2mutant XY gonads. (B) (i) Hematoxylin and eosin staining of sections of paraffin-embedded mutant and control
embryos at E14.5 (Enlargements of the anterior regions of the gonads are shown). At the anterior pole of Fgfr2 mutant XY gonads, testis cords are absent, and germ
cells have entered prophase of meiosis (arrowheads). (ii) Top panel: Fluorescence microscopy of frozen sections of Fgfr2 mutant XY and control gonads at E14.5
double immunostained for AMH (red, cytoplasmic) and SCP3 (green, nuclear), a marker of female meiotic germ cells. Second panel: Whole mount in situ
hybridization for the meiotic marker DmcI of E14.5 Fgfr2 mutant XYand control gonads. Third panel: Whole mount in situ hybridization for the pre-meiotic marker
Stra8 of E14.5 Fgfr2 mutant XY and control gonads. Bottom panel: Whole mount in situ hybridization for Cyp26b1 of E14.5 Fgfr2 mutant XY and control gonads.
Arrows denote the SCP3-, DmcI- and Stra8-positive and Cyp26b1-negative poles of Fgfr2 mutant XY gonads. The presence of somatic female markers and of
meiosis markers indicates that the poles of Fgfr2 mutant XY gonads are sex reversed. All scale bars are 50 μm.
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gonads, Pgds was still expressed within the testis cords,
similar to SOX9 (Fig. 3C, upper panel and Fig. 5B(ii)). These
data indicate that the SOX9–PGDS–PGD2 pathway acts
independently of FGFR2.FGF9 does not bind to the coelomic epithelium of Fgfr2 mutant
XY gonads
It has been recently demonstrated that FGF9 binds to the
coelomic surface of the E11.5 XY gonad (Schmahl et al.,
Fig. 5. C57BL6 exacerbates XY sex reversal of Fgfr2 mutant XY gonads. (A) Light microscopy images of Fgfr2 mutant (129/B6*) XYand control gonads at E14.5.
Fgfr2mutant (129/B6*) XY gonads appear as ovotestes, or have a size and shape very similar to a female gonad. The male-specific coelomic blood vessel is restricted
to regions with testis cords. (B) (i) Fluorescence microscopy of frozen sections of XYand XX control gonads at E14.5 double immunostained for SOX9 (green, nuclear
and AMH (red, cytoplasmic). (ii) Top, middle and bottom panels: Fluorescence microscopy of frozen sections of Fgfr2 mutant XY gonads at E14.5 (with increasing
severity from top to bottom) double immunostained for SOX9 (green, nuclear) and AMH (red, cytoplasmic). (C) Upper panel: Fluorescence microscopy of frozen
sections of Fgfr2 mutant XY and control gonads at E14.5 immunostained for AMH (red, cytoplasmic). Lower panel: Whole mount in situ hybridization for Bmp2 of
E14.5 Fgfr2 mutant XYand control gonads. Dotted lines denote the borders between ovarian and testicular tissue. o, ovarian portion of the Fgfr2 mutant ovotestis; t,
testicular portion of the Fgfr2 mutant ovotestis. All scale bars are 50 μm.
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at this time, it has been speculated that FGF9 signals through
FGFR2. In order to test whether FGF9 binding is abolished in
Fgfr2 mutant XY gonads, we performed in situ bindingassays with human FGF9 as previously described (Schmahl et
al., 2004). While FGF9 accumulated at the coelomic
epithelium of E11.5 XY gonads, both XX and Fgfr2 mutant
XY gonads (3 pairs of gonads per genotype) did not
Fig. 6. Analysis of Pgds expression in Fgfr2 mutant XY gonads. Upper panel: Whole mount in situ hybridization for Pgds of E13.5 Fgfr2 mutant XY and control
gonads. Lower panel: Whole mount in situ hybridization for Pgds of E14.5 Fgfr2 mutant (129/B6*) XY and control gonads. Arrows point to the Pgds-negative
regions of Fgfr2 mutant and Fgfr2 mutant (129/B6*) XY gonads. In Fgfr2 mutant XY gonads, except for the poles, Pgds is still strongly expressed throughout the
gonad, while in Fgfr2 mutant (129/B6*) XY gonads, Pgds is lost from the anterior region of the gonad.
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be noted that due to the chimeric character of the Ck19:Cre
mouse line, we occasionally observed FGF9 binding also in
Fgfr2 mutant XY gonads.Fig. 7. FGF9 does not bind to the coelomic epithelium of Fgfr2 mutant XY
gonads. E11.5 gonad sections were incubated with human FGF9, which was
detected with an antibody specific to the human FGF9 protein (green). Human
FGF9 bound to the coelomic epithelium in E11.5 XY gonad sections, but not in
E11.5 XX and XY Fgfr2mutant gonad sections. Arrowheads denote the surface
of the coelomic epithelium.FGFR2 nuclear localization is dependent on SOX9
Following SRY mediated up-regulation of SOX9 at
E11.5, FGFR2 accumulates in the Sertoli cell nuclei of
XY gonads (Schmahl et al., 2004). The importance of
FGFR2 nuclear localization for Sertoli cell differentiation
and testis development has been recently demonstrated by
Kim et al. (2007). It has been previously shown that E11.5
Sox9 knockout gonads do not express Fgf9 (Kim et al.,
2006), and that, in E12.5 Fgf9 knockout gonads lacking
SOX9, FGFR2 is not nuclear (Schmahl et al., 2004; Kim et
al., 2006). However, FGFR2 nuclear localization in Sox9
knockout gonads has not been studied. To test directly
whether SOX9 affects the nuclear localization of FGFR2, we
performed immunohistochemistry for FGFR2 in Ck19:Cre/+;
Sox9flox/flox (‘Sox9 mutant’) XY gonads at E11.5, the time
when FGFR2 is normally translocated into the nucleus.
Strong nuclear staining in pre-Sertoli cells of SRY, SOX9
and FGFR2 was observed in E11.5 wild type XY gonads,
while in wild type XX gonads, only FGFR2 was detectable
(Fig. 8), localized at the plasma membrane and in the
cytoplasm. In Sox9 mutant XY gonads, though SRY was
expressed (Fig. 8, upper panel), FGFR2 was localized at the
membrane and in the cytoplasm, similar to FGFR2 localiza-
tion in wild type XX gonads (Fig. 8, lower panel),
demonstrating that SOX9, rather than SRY, is required for
the nuclear localization of FGFR2. Thus SOX9 and FGFR2
seem linked, with the ability to re-inforce the action of one
another. In a previous study, we demonstrated that Sry gene
expression at E11.5 is unaffected in Sox9 mutant XY gonads
(Barrionuevo et al., 2006). Here we extend our findings to
show that SRY protein expression and nuclear localization
are also unaltered.
Fig. 8. SOX9 is required for nuclear localization of FGFR2. Fluorescence microscopy of frozen transverse sections of Sox9 mutant XY and control embryos at early
E11.5 (15 tail somites) double immunostained for SRY (green, nuclear) and SOX9 (red, nuclear) (upper panel), and immunostained for FGFR2 (lower panel). Dashed
lines mark the perimeter of Sox9 mutant XY and control gonads. The inserts in the lower panel show magnification of cells stained for DAPI (blue, nuclear) and
FGFR2 (green, nuclear in the wild type XY gonad, cytoplasmic in the Sox9 mutant XY gonad and in the wild type XX gonad). In Sox9 mutant XY gonads, though
SRY was expressed, FGFR2 was localized at the membrane and in the cytoplasm, similar to FGFR2 localization in wild type XX gonads. Note that FGFR2 nuclear
localization is a dynamic process. At early E11.5, only a few FGFR2-positive nuclei are present within the gonad, while by late E11.5, that number has increased
(Schmahl et al., 2004). Similarly, at early E11.5, FGFR2 expression at the XY coelomic epithelium is barely detectable, while by late E11.5, FGFR2 expression is
much stronger (Schmahl et al., 2004). We could only examine early E11.5 XY wild type controls because most of the Sox9mutants do not survive beyond early E11.5.
All scale bars are 50 μm.
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XY gonadal sex reversal
Given that FGFR2 loss can lead to a drastic reduction in the
number of SOX9-expressing cells (Fig. 5B(ii), bottom panel),
and that FGFR2 nuclear localization is dependent on SOX9, we
examined the functional relationship between FGFR2 and
SOX9 in vivo. We generated double heterozygous Fgfr2/Sox9
knockout mice (CMV:Cre;Fgfr2floxdel/+;Sox9flox/+) using the
CMV:Cre mouse line (Schwenk et al., 1995).
Fgfr2/Sox9 knockout embryos were recovered at the
expected Mendelian ratio, but died immediately after birth. In
contrast to Fgfr2 or Sox9 single heterozygous mutant XY
gonads which developed as normal testes (data not shown),
double heterozygous Fgfr2/Sox9 knockout XY gonads devel-
oped as ovotestes and were very similar in appearance to Fgfr2
mutant XY gonads. Of 24 XY Fgfr2/Sox9 knockout gonads
between E12.5 and E15.5, 20 displayed ovotestes (6 at E12.5, 2
at E13.5, 10 at E14.5 and 2 at E15.5), while 4 (2 at E12.5 and 2
at E14.5) showed no defects in testis cord formation.
Immunohistochemistry of Fgfr2/Sox9 knockout XY gonads
at E12.5 showed that the number of SOX9- and AMH-positive
cells was greatly reduced near the poles, particularly at the
anterior pole (Fig. 9A(i), top and middle panels). By E14.5,
SOX9 and AMHwere completely absent at the poles, indicating
a failure of Sertoli cell differentiation (Fig. 9A(ii)) similar to that
of Fgfr2 mutants (Fig. 3C). Remarkably, while strong nuclear
FGFR2 expression was visible in the wild type XY male gonad,
FGFR2 expression was barely detectable throughout the entireFgfr2/Sox9 knockout gonad (Fig. 9A(i), bottom panel). In
contrast, Fgfr2 or Sox9 single heterozygous knockouts showed
no obvious defects of SOX9 or FGFR2 immunostaining,
respectively (data not shown). It appears that in Fgfr2/Sox9
knockout gonads the SOX9–FGFR2 signaling loop is weakened
to just below the threshold required to efficiently maintain
nuclear FGFR2 expression, while SOX9 may still be main-
tained, most likely through the Prostaglandin signaling pathway.
The poles of Fgfr2/Sox9 knockout XY gonads expressed the
female somatic marker Bmp2 (Fig. 9B, upper panel), and the
meiosis markers SCP3 (Fig. 9B, lower panel) and Dmc1 (data
not shown), indicating that these regions of the gonad were sex
reversed.
Discussion
XY gonadal dysgenesis in humans arises from mutations in
testis-determining genes and duplications of anti-testis genes,
which together explain some 20% of these DSD conditions,
implying that a number of sex-determining genes remain
undiscovered. FGF9 is essential for sex determination in mice
and it is reasonable to postulate that FGF9 and its receptor(s)
would be sex-determining genes in humans. We considered
Fgfr2 a candidate testis-determining gene, since (a) it encodes a
potential receptor for FGF9 during male sex determination, (b)
knockout mice of the other FGF receptors, FGFR1, FGFR3 and
FGFR4 show no obvious gonadal phenotype and (c) FGFR2
protein shows male-specific localization in the nuclei of Sertoli
cell precursors (Schmahl et al., 2004). Here, we successfully
Fig. 9. Fgfr2/Sox9 double heterozygous knockout mice show partial XY gonadal sex reversal. (A) (i) Fluorescence microscopy of frozen sections of Fgfr2/Sox9
knockout and control gonads at E12.5 immunostained for SOX9 (green, nuclear) (top panel), AMH (red, cytoplasmic) (middle panel) and FGFR2 (green, nuclear)
(bottom panel). Note that while SOX9 and AMH immunohistochemistry has been performed on the same gonad section, the sections immunostained for SOX9/AMH
and FGFR2 are not consecutive. In Fgfr2/Sox9 knockout gonads, the number of SOX9- and AMH-expressing cells was drastically reduced at the anterior pole
(framed). Moreover, while XY control gonads show strong FGFR2 expression, FGFR2 is barely detectable throughout the entire Fgfr2/Sox9 knockout gonad. (ii)
Fluorescence microscopy of frozen sections of Fgfr2/Sox9 knockout and control gonads at E14.5 double immunostained for SOX9 (green, nuclear) and AMH (red,
cytoplasmic). By E14.5, SOX9 and AMH expression is absent from the poles of Fgfr2/Sox9 knockout gonads (framed). (B) Upper panel: Whole mount in situ
hybridization for Bmp2 of E14.5 Fgfr2/Sox9 knockout and control gonads. Arrows point to the Bmp2-positive poles of the Fgfr2/Sox9 knockout gonad. Lower panel:
Fluorescence microscopy of frozen sections of Fgfr2/Sox9 knockout and control gonads at E14.5 double immunostained for AMH (red, cytoplasmic) and SCP3
(green, nuclear). Arrowheads denote SCP3-positive cells at the poles of the Fgfr2/Sox9 knockout XY gonad. All scale bars are 50 μm.
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specifically within the embryo proper (epiblast) (Means et al.,
2005), circumventing the early embryonic lethality of complete
Fgfr2 knockout embryos.
Fgfr2 is required for male sex determination
In this study, we identify Fgfr2 as an important player during
male sex determination. Fgfr2mutant XY mice on a mixed 129/
C57BL6-background had either normal testes, or showed partial
sex reversal with ovarian tissue restricted to the gonad poles.
However, one backcross to C57BL6 (B6), a mouse strain
exquisitely sensitive to XY sex reversal, resulted in more
dramatic XY sex reversal, with gonadal phenotypes ranging
from hypoplastic testes and ovotestes, to gonads the size and
shape of ovaries with an almost complete absence of Sertoli
cells. Similarly, Fgf9 knockout mice on a mixed 129/B6-
background with unknown B6 contribution showed a wide
range of gonadal phenotypes, from disorganized testis struc-
tures, to complete absence of testis-specific markers (Colvin et
al., 2001). It may be speculated that further backcrosses to B6
would result in a more penetrant sex-reversal phenotype of
Fgfr2 mutant XY gonads as has been demonstrated for Fgf9
knockout mice (Colvin et al., 2001; Schmahl et al., 2004).
Given the remarkably similar phenotypes of Fgfr2 mutant (129/
B6*) and Fgf9 knockout mice on a mixed 129/B6 background,
and since typical male-specific FGF9-binding to the coelomic
epithelium was abolished in Fgfr2 mutant XY gonads, we
suggest that FGFR2 acts as the receptor for FGF9 during male
gonadal development. Recently, a SOX9–FGF9 positive
signaling loop has been postulated in the male gonad (Kim et
al., 2006). SOX9 initiates Fgf9 transcription, and FGF9
maintains SOX9 expression and induces nuclear localization
of FGFR2 in Sertoli cell precursors (Schmahl et al., 2004).
Here, we extend these findings by showing directly that SOX9
is required for FGFR2 nuclear localization and conversely, that
FGFR2 is important for the maintenance of SOX9 expression.
These results suggest that FGFR2 and SOX9 regulate each other
through a SOX9–FGF9–FGFR2 positive signaling loop. The
molecular consequences of SOX9-mediated FGFR2 nuclear
localization via FGF9 remain to be elucidated.
Just recently, a paper similar to ours has been published (Kim
et al., 2007). The authors show that FGFR2 expression in both
the coelomic epithelium and the Sertoli cells is important for
testis development. In contrast to our data, early inactivation of
Fgfr2 always led to a complete XY sex-reversal phenotype.
This difference of phenotype is most likely attributable to a
different contribution of the B6 mouse strain.
The FGF9/FGFR2 and PGDS/PGD2 pathways appear to act
independently to maintain SOX9 expression in the XY gonad
While XY Fgfr2 mutant (129/B6*) ovotestes contain a
majority of ovarian tissue, they still expressed SOX9 and AMH
in the center. Similarly, inFgf9 knockout mice on a mixed 129/B6
background, over 50% of E13.5/E14.5 gonads displayed testis
cords and robustly expressed SOX9 and AMH (Colvin et al.,2001). These two independent observations suggest that SOX9
expression is not solely dependent on FGFR2 or FGF9. Recently,
a second positive signaling loop, PGDS–PGD2–SOX9, has been
postulated to maintain SOX9 expression in the developing male
gonad (Malki et al., 2005; Wilhelm et al., 2005, 2007). We found
that Pgds was still strongly expressed in the SOX9-expressing
center of Fgfr2 mutant XY gonads, suggesting that the PGDS–
PGD2 pathway can maintain SOX9 expression independently of
FGFR2. However, the critical experiment to show that the
Prostaglandin pathway can indeed maintain SOX9 expression in
this system would be the analysis of double Fgfr2/Pgds knockout
mice. At the poles of the gonad in the absence of FGFR2, the
PGDS–PGD2 pathway apparently cannot efficiently maintain
SOX9 expression. That SOX9, AMH, Cyp26b1 and Pgds
expression was lost specifically at the gonad poles may be
attributable to the fact that SRYand SOX9 expression is strongest
in the center of the gonad (Bullejos andKoopman, 2001; Schepers
et al., 2003;Wilhelm et al., 2005),making the polesmore sensitive
to XY sex reversal. In accordancewith our observations, ovotestes
generally form with testicular tissue at the center and with ovarian
tissue at the gonad poles (Eicher et al., 1980).
FGFR2 and human XY sex reversal
The demonstration of Fgfr2 as a sex-determining gene in
mice renders human FGFR2 a candidate gene for unsolved DSD
(disorders of sexual development) cases. Indeed, human patients
with terminal deletions of chromosome 10q26 spanning the
10q26.13 region, which includes the FGFR2 locus, show
abnormal sexual differentiation, frommicropenis and cryptorch-
idism, to partial XY sex reversal, and occasionally complete XY
sex reversal with gonadal dysgenesis (Wilkie et al., 1993 and
references therein). This suggests that the abnormal sexual
phenotype in cases with terminal 10q26 deletions is associated
with insufficient gene dosage (haploinsufficiency). The sex-
reversal phenotype of double heterozygous Fgfr2/Sox9 XY
knockout mice also results from reduced levels of the FGFR2
protein, which supports the notion for a threshold activity of
FGFR2 for normal testis development. Though mutations in
human FGFR2 have been well characterized and do not seem to
result in XY sex reversal, these mutations alter the function of
the FGF receptor 2 and do not lead to a loss of function as is the
case for the Fgfr2 knockout mice. Like SOX9 gene mutations
that cause XY sex reversal when heterozygous in humans but not
in mice (Barrionuevo et al., 2006; Chaboissier et al., 2004;
Foster et al., 1994; Wagner et al., 1994), we speculate that a
heterozygous inactivating mutation in human FGFR2 may lead
to DSD, despite the fact that heterozygous Fgfr2 mutant XY
mice show a normal male phenotype. That Sox9/Fgfr2
heterozygous mice show an intersex phenotype raises the
possibility of compound heterozygous mutations/polymorph-
isms causing human DSD conditions.
Conclusion
We show that FGFR2 is important for male sex determination
since (i)Fgfr2mutant XYmice show gonadal male-to-female sex
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mixed 129/C57BL6 background, (ii) Fgfr2/Sox9 double hetero-
zygous XY knockout mice show gonadal male-to-female sex
reversal and (iii) FGF9 does not bind to the coelomic epithelium
of Fgfr2 mutant XY gonads. Taken together, our data support




Generation of XY Ck19:Cre/+;Fgfr2flox/flox embryos
Fgfr2flox/flox (whose Fgfr2 exons 8 and 10 are flanked by loxP sites) on a
mixed 129/C57BL6 genetic background (Yu et al., 2003) were crossed with the
Ck19:Cre/+ (C57BL6) transgenic mouse line (Means et al., 2005). Resultant
Ck19:Cre/+;Fgfr2flox/+ offspring were backcrossed to Fgfr2flox/flox mice to
obtain XY Ck19:Cre/+;Fgfr2flox/flox embryos. The conditional Fgfr2 allele
interferes with the expression of both Fgfr2-IIIb and Fgfr2-IIIc isoforms (Yu et
al., 2003).
Generation of XY Ck19:Cre/+;Fgfr2flox/flox embryos (129/B6*)
Ck19:Cre/+;Fgfr2flox/+ and Fgfr2flox/flox mice were crossed to C57BL6 for
one generation. Resultant Ck19:Cre/+;Fgfr2flox/+(129/B6*) and Fgfr2flox/+
(129/B6*) mice were crossed with each other to generate XY Ck19:Cre/+;
Fgfr2flox/flox embryos (129/B6*).
Generation of XY CMV:Cre;Fgfr2floxdel/+;Sox9flox/+ embryos
Male CMV:Cre/+ mice (Schwenk et al., 1995) were crossed with female
Fgfr2flox/flox mice to obtain female CMV:Cre;Fgfr2floxdel/+ mice. These female
mice were then crossed with Sox9floxflox mice to generate XY CMV:Cre;
Fgfr2floxdel/+;Sox9flox/+ embryos.
Ck19:Cre/+;Sox9floxflox embryos were generated as previously described
(Barrionuevo et al., 2006).
Embryoswere harvested at E11.5–E15.5 days gestationwith day 0.5 designated
as the morning the plug was identified. All procedures involving mice were
approved by the Animal Ethics Committee of Monash University, Australia.
Genotyping of mouse embryos
Genomic DNAwas isolated from the yolk sac for genotyping. Primers and
PCR conditions for the Cre and Sox9flox (Barrionuevo et al., 2006) and for
Fgfr2flox and Fgfr2floxdel alleles (Yu et al., 2003) were used as previously
described. Embryos were sexed by PCR using primers based on the mouse Smcx
and Smcy genes as previously described (Barrionuevo et al., 2006).
Whole mount analyses of gonads
Embryos from E13.5 to E15.5 were collected in cold phosphate-buffered
saline (PBS). The gonads were dissected out of the embryos, fixed in 4% PFA
overnight at 4 °C and documented using a Zeiss Stemi SV11 stereomicroscope.
Histological analyses
For histology, embryos at E13.5 and E14.5 were collected in PBS, fixed in
Serra (ethanol: 37% formaldehyde:acetic acid, 6:3:1) overnight at 4 °C,
embedded in paraffin and sectioned at 5–6 μm. Staining of sections with
hematoxylin and eosin followed standard techniques.
Cryosection and Immunofluorescence
Fetal gonads between E11.5 and E14.5 were dissected in PBS and fixed in
4% PFA/PBS for 3 h at 4 °C. They were washed twice in PBS, incubated for 1 hin 15% sucrose/PBS and then overnight in 30% sucrose/PBS at 4 °C. Samples
were embedded in OCT medium (Tissue-Tek) and frozen at −70 °C, and serial
5 μm sections were cut with a cryostat (Leica) ((Gasca et al., 2002) with some
modifications). Indirect immunofluorescence staining was performed using the
primary antibodies to SOX9 (Morais da Silva et al., 1996), FGFR2 (Santa Cruz;
sc-122), AMH (Santa Cruz; sc-6886), SCP3 (Abcam; ab15092) and SRY
(Abcam; ab22166) with Alexa dye-linked secondary antibodies (Molecular
Probes, Carlsbad, CA). Images were captured using fluorescence microscopy
(Olympus Corp., NY).
In situ FGF9 binding assay
FGF9 in situ binding assays were performed as previously described
(Schmahl et al., 2004). E11.5 frozen sections (12 μm) of XY control, XX control
and XY Fgfr2 mutant gonads were treated with human FGF9 protein (0.7 μg/
ml) (R&D systems; AF-273-NA), which was detected by an antibody specific to
human FGF9 (R&D systems; 273-F9).
Whole mount in situ hybridization
Gonads between E12.5 and E14.5 were dissected in DEPC treated PBS,
fixed in 4% PFA/DEPC overnight at 4 °C, dehydrated through a methanol series
and stored at −20 °C. Whole mount in situ hybridization of gonads with probes
for Wnt4 (Vainio et al., 1999), Pgds (kindly provided by Dagmar Wilhelm) and
Stra8, Dmc1, Cyp26b1, Fst and Bmp2 (kindly provided by Josephine Bowles)
was performed as described (Zheng et al., 2001), with some modifications.Acknowledgments
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